Answer
Kisunla (donanemab) has no or negligible influence on the ability to drive and use machines.
Sources for this answer
- Kisunla 350 mg concentrate for solution for infusionEli Lilly and Company Limited · emc · SmPC §4.7 Effects on ability to drive and use machines · Version 3Document updated
Sources checked